December 12, 2022, 11:00 a.m. CT
View this webinar, presented by Michele Grigaitis-Reyes, DNP FNP-BC CNRN FAAN on the pharmacologic management of Alzheimer's disease. Michele will be presenting an extended version of this topic at the Neuro-APP Conference in January 2023, so we hope you will join us for her talk, as well as several other talks from your esteemed APP colleagues. You can find more information on the APP Conference here.
Participants can receive 0.75 CE contact hour for attending or viewing the webinar and completing the evaluation.
Learning Outcomes:
1.Identify approved pharmacologic agents approved for the use in Alzheimer'sdisease and associated potential adverse effects.
2.Identify the use of pharmacologic agents to address Behavioral and Psychological Symptoms of Dementia (BPSD)
3.Identify evidenced based strategies for disease prevention and risk modification.